Resmed Inc (RMD) Stock Price, Quote & News

Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry,...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 858-836-5000

Website: www.resmed.co.in

Address:

9001 Spectrum Center Boulevard, San Diego, United States

Pal5757 Nov. 3 at 11:46 PM

$IXHL $RMD is not going anywhere. There will be individuals that will require to use a CPAP machine. Maybe IXHL will make a breathable concoction instead of using distilled water that is used in most of the CPAP machines. Both can be effective and profitable. It would be nice to do one stop shopping but that would be up to $RMD. It’s a not brainer to me but in the end, I just hold shares.

0 · Reply

LiquidThetaOptions Nov. 3 at 11:33 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $247.25 Contracts: $RMD January 15, 2027 $250 Calls Scale in: $52.50- $64.16 Scale out: $81.66-$104.99 Can Easily Capture: 60% ROI Blended DTE: 438 Days | Join Elites here: https://liquidtheta.com

0 · Reply

macdub8 Nov. 3 at 1:42 PM

$RMD the sinking ship? $IXHL has a lifeboat waiting for you

2 · Reply

JarvisFlow Nov. 3 at 12:33 PM

Baird updates rating for ResMed ( $RMD ) to Outperform, target set at 320 → 300.

0 · Reply

macdub8 Nov. 3 at 11:21 AM

$RMD Resmed is down $46 (%15) since August. We all know why... $IXHL is the future and the market is seeing this. RMDs earnings call last week was about as inspiring as a RyanAir safety briefing

1 · Reply

LiquidThetaOptions Nov. 3 at 12:42 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $246.88 Contracts: $RMD January 15, 2027 $250 Calls Scale in: $41.89- $51.19 Scale out: $65.16-$83.77 Can Easily Capture: 60% ROI Blended DTE: 439 Days | Join Elites here: https://liquidtheta.com

0 · Reply

Halo202 Nov. 2 at 10:21 PM

$RMD $255+ by Friday

0 · Reply

__SquuezedChronometer_ Nov. 2 at 11:11 AM

Next major retail squeeze candidate right here $RMD $EC $CEPT $LION >

0 · Reply

LiquidThetaOptions Nov. 2 at 1:05 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $246.88 Contracts: $RMD January 15, 2027 $250 Calls Scale in: $41.89- $51.19 Scale out: $65.16-$83.77 Can Easily Capture: 60% ROI Blended DTE: 440 Days | Join Elites here: https://liquidtheta.com

0 · Reply

Chapman211 Nov. 1 at 9:28 PM

$RMD $IXHL I haven’t read up on this but does anyone know why $RMD has dropped 40 dollars this past month? Pill is definitely the move going forward imo.

1 · Reply

These Analysts Revise Their Forecasts On ResMed Following Q1 Results

Oct 30, 2025, 10:16 PM EDT - 4 days ago

ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript

Oct 30, 2025, 4:05 PM EDT - 4 days ago

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026

Oct 9, 2025, 4:05 PM EDT - 25 days ago

Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025

Oct 3, 2025, 10:46 AM EDT - 4 weeks ago

Top 50 High-Quality Dividend Growth Stocks For October 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Sep 23, 2025, 11:53 AM EDT - 5 weeks ago

ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Sep 16, 2025, 4:05 PM EDT - 6 weeks ago

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

Sep 8, 2025, 9:00 PM EDT - 2 months ago

The sleep economy is 'having a moment', says medical equipment firm Resmed

Sep 6, 2025, 12:18 PM EDT - 2 months ago

Top 50 High-Quality Dividend Stocks For September 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Sep 3, 2025, 4:15 PM EDT - 2 months ago

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Aug 27, 2025, 9:00 AM EDT - 2 months ago

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Aug 27, 2025, 7:43 AM EDT - 2 months ago

ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows

Aug 18, 2025, 4:15 PM EDT - 2 months ago

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Aug 6, 2025, 11:50 AM EDT - 3 months ago

Top 50 High-Quality Dividend Stocks For August 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Aug 1, 2025, 2:16 PM EDT - 3 months ago

ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings

Jul 31, 2025, 9:39 PM EDT - 3 months ago

ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript

Jul 31, 2025, 4:53 PM EDT - 3 months ago

Resmed beats quarterly profit estimates on strong demand for sleep devices

Jul 31, 2025, 4:05 PM EDT - 3 months ago

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

Jul 30, 2025, 6:08 AM EDT - 3 months ago

Spot Outliers Like ResMed Early with Money Flows

Jul 1, 2025, 9:02 PM EDT - 4 months ago

Top 15 High-Growth Dividend Stocks For July 2025

APH BAC BK DKS DPZ ELV GPN

Jul 1, 2025, 4:05 PM EDT - 4 months ago

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

Jun 9, 2025, 5:38 AM EDT - 5 months ago

ResMed: A Sleeping Giant Hiding In Plain Sight

Jun 2, 2025, 10:00 AM EDT - 5 months ago

Top 15 High-Growth Dividend Stocks For June 2025

DKS DPZ GPN INTU KLAC LRCX MPWR

May 15, 2025, 9:00 AM EDT - 6 months ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

May 2, 2025, 11:21 AM EDT - 6 months ago

Top 15 High-Growth Dividend Stocks To Consider For May 2025

AMAT APH DKS DPZ GPN INTU LRCX

May 1, 2025, 9:00 AM EDT - 6 months ago

Resmed Acquires VirtuOx

Apr 24, 2025, 3:24 PM EDT - 6 months ago

ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

Apr 24, 2025, 5:12 AM EDT - 6 months ago

ResMed: Cornering The Market In Sleep Solutions

Apr 23, 2025, 7:16 PM EDT - 6 months ago

ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript

Apr 23, 2025, 5:08 PM EDT - 6 months ago

ResMed slightly beats quarterly profit estimates on sleep devices demand

Apr 23, 2025, 4:05 PM EDT - 6 months ago

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Apr 21, 2025, 5:00 PM EDT - 7 months ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Apr 3, 2025, 9:00 AM EDT - 7 months ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Apr 2, 2025, 4:05 PM EDT - 7 months ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Apr 2, 2025, 2:12 AM EDT - 7 months ago

My Top 15 High-Growth Dividend Stocks For April 2025

AMAT APH DPZ GPN INTU LRCX MPWR

Mar 19, 2025, 8:00 AM EDT - 8 months ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Mar 11, 2025, 9:00 AM EDT - 8 months ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Mar 3, 2025, 4:34 PM EST - 8 months ago

My Top 15 High-Growth Dividend Stocks For March 2025

APH DPZ GPN INTU KLAC LRCX MPWR

Feb 26, 2025, 3:00 AM EST - 8 months ago

ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Feb 11, 2025, 4:30 AM EST - 9 months ago

Jan De Witte joins GHO Capital as Operating Partner

IART

Feb 10, 2025, 10:38 AM EST - 9 months ago

Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions

Feb 3, 2025, 12:59 PM EST - 9 months ago

Stock Of The Day: Trading The Range In ResMed

Jan 30, 2025, 9:10 PM EST - 9 months ago

ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript

Jan 30, 2025, 5:21 PM EST - 9 months ago

ResMed beats quarterly profit estimates on demand for sleep disorder devices

Jan 30, 2025, 4:05 PM EST - 9 months ago

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025

Jan 12, 2025, 12:52 PM EST - 10 months ago

Top 50 High Quality Dividend Growth Stocks - January 2025

MA MPWR MSCI QCOM RACE ROL ZTS

Jan 9, 2025, 4:05 PM EST - 10 months ago

ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

Jan 6, 2025, 4:05 PM EST - 10 months ago

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 10:49 PM EST - 10 months ago

My Top 15 High Growth Dividend Stocks For January 2025

APH DPZ ELV GPN INTU MA MPWR

Dec 23, 2024, 2:59 PM EST - 11 months ago

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

INSP LLY

Pal5757 Nov. 3 at 11:46 PM

0 · Reply

LiquidThetaOptions Nov. 3 at 11:33 PM

0 · Reply

macdub8 Nov. 3 at 1:42 PM

$RMD the sinking ship? $IXHL has a lifeboat waiting for you

2 · Reply

JarvisFlow Nov. 3 at 12:33 PM

Baird updates rating for ResMed ( $RMD ) to Outperform, target set at 320 → 300.

0 · Reply

macdub8 Nov. 3 at 11:21 AM

$RMD Resmed is down $46 (%15) since August. We all know why... $IXHL is the future and the market is seeing this. RMDs earnings call last week was about as inspiring as a RyanAir safety briefing

1 · Reply

LiquidThetaOptions Nov. 3 at 12:42 AM

0 · Reply

Halo202 Nov. 2 at 10:21 PM

$RMD $255+ by Friday

0 · Reply

__SquuezedChronometer_ Nov. 2 at 11:11 AM

Next major retail squeeze candidate right here $RMD $EC $CEPT $LION >

0 · Reply

LiquidThetaOptions Nov. 2 at 1:05 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $246.88 Contracts: $RMD January 15, 2027 $250 Calls Scale in: $41.89- $51.19 Scale out: $65.16-$83.77 Can Easily Capture: 60% ROI Blended DTE: 440 Days | Join Elites here: https://liquidtheta.com

0 · Reply

Chapman211 Nov. 1 at 9:28 PM

$RMD $IXHL I haven’t read up on this but does anyone know why $RMD has dropped 40 dollars this past month? Pill is definitely the move going forward imo.

1 · Reply

SuperGreenToday Nov. 1 at 4:22 AM

$RMD Share Price: $246.89 Contract Selected: Apr 17, 2026 $250 Calls Buy Zone: $15.89 – $19.64 Target Zone: $28.15 – $34.40 Potential Upside: 67% ROI Time to Expiration: 167 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

LiquidThetaOptions Oct. 31 at 10:56 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $241.99 Contracts: $RMD January 15, 2027 $250 Calls Scale in: $41.44- $50.64 Scale out: $64.46-$82.87 Can Easily Capture: 60% ROI Blended DTE: 441 Days | Join Elites here: https://liquidtheta.com

0 · Reply

1ightningscalps Oct. 31 at 10:47 PM

1ightning® Options Trade Alert (Actionable) | Buy $RMD Nov 21 $250 Call | Enter: $11.98 Exit: $15.93 | Profit: 33.01% ROI | https://1ightning.com

0 · Reply

Rackjaw Oct. 31 at 2:56 PM

$RMD a slow drip down here until they buyout IXHL...So raise the offer instead of shorting it.

0 · Reply

ZacksResearch Oct. 31 at 1:00 PM

$RMD pops 3.1% after earnings beat — what drove the jump? 🚀 Adjusted EPS climbed 15.9% YoY to $2.55, surpassing estimates by 2.41%, while revenue rose 9.1% to $1.34B, also beating forecasts. Strong performance in Sleep and Breathing Health, Residential Care Software, and expanding margins fueled the growth. See the full earnings breakdown here 👉 https://www.zacks.com/stock/news/2782413/resmed-stock-up-on-q1-earnings-revenue-beat-margins-expand?cid=sm-stocktwits-2-2782413-body-18745&ADID=SYND_STOCKTWITS_TWEET_2_2782413_BODY_18745

0 · Reply

ZacksResearch Oct. 31 at 12:00 PM

$RMD pops after a strong Q1 beat 🔥 Earnings and revenue both topped estimates, and margins expanded — signaling improving profitability and solid execution. Full breakdown on what’s driving the upside 👉 https://www.zacks.com/stock/news/2782413/resmed-stock-up-on-q1-earnings-revenue-beat-margins-expand?cid=sm-stocktwits-2-2782413-teaser-18727&ADID=SYND_STOCKTWITS_TWEET_2_2782413_TEASER_18727

0 · Reply

LiquidThetaOptions Oct. 31 at 9:01 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $252.26 Contracts: $RMD January 15, 2027 $260 Calls Scale in: $33.11- $40.46 Scale out: $51.50-$66.21 Can Easily Capture: 60% ROI Blended DTE: 441 Days | Join Elites here: https://liquidtheta.com

0 · Reply

Askar172 Oct. 30 at 10:52 PM

$RMD might need $IXHL 🚀 Sleep apnea is their market, but IXHL’s IHL‑42X could be the game-changer. Big synergy potential if they team up! 🌙💊

2 · Reply

LiquidThetaOptions Oct. 30 at 10:23 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RMD Current Share Price: $256.31 Contracts: $RMD January 15, 2027 $260 Calls Scale in: $34.26- $41.88 Scale out: $53.30-$68.53 Can Easily Capture: 60% ROI Blended DTE: 442 Days | Join Elites here: https://liquidtheta.com

0 · Reply

macdub8 Oct. 30 at 9:38 PM

$IXHL listened to the $RMD earnings call. Didn't address acqusitions, pills or anything directly IXHL related. The Q&A was clearly orchestrated IMO..a lot of back patting. "Thats a great question..". Suspiciously all extremely well-spoken people using very deliberate vocab. RMD are releasing 2 new masks which move away from rubber silicone and utilise a supposedly gentler fabric. The idea being that its the same as having the same material of your sheets on your face (weird selling point). Focusing on their 'end to end' sleep technology product. All in all a truly uninspiring call which reeks of complacency

3 · Reply

Firedbeef Oct. 30 at 9:09 PM

$IXHL anyone listening in on $RMD earnings call? Would love any nuggets about pills, partnerships, etc. thank you

1 · Reply

ssolingen Oct. 30 at 8:56 PM

$RMD Saw the indian Dr. (Patel gupta or something) on detroit local affiliate 5 o'clock news pushing this stock. Then, my barber told me about it as a hot stock tip. Morgan Stanley changes rating to "overweight" Is he wearing a toupee, pushing face masks in an earnings call? Hard pass...

0 · Reply

Market Cap	36.03B
Revenue (ttm)	5.15B
Net Income (ttm)	1.40B
EPS (ttm)	N/A
PE Ratio	25.48
Forward PE	23.46
Profit Margin	27.22%
Debt to Equity Ratio	0.11

Volume	1,596,200
Avg Vol	1,027,712
Day's Range	N/A - N/A
Shares Out	145.94M
Stochastic %K	31%
Beta	0.83
Analysts	Sell
Price Target	$293.54